CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 78.1% of retail investor accounts lose money when trading CFDs with this provider. You should consider whether you understand how CFDs work and whether you can afford to take the high risk of losing your money.
US English
156.65
0.92%
Market Trading Hours* (UTC) Opens on Tuesday at 09:10

Mon: 09:10 - 00:00

Tue - Thu: 00:00 - 01:00 09:10 - 00:00

Fri: 00:00 - 01:00 09:10 - 22:00

  • Summary
  • Historical Data
  • Events
  • Income Statement
  • Balance Sheet
  • Cash Flow
  • Ownership
Trading сonditions
Spread 0.26
Long position overnight fee

Long position overnight fee


Margin. Your investment $1,000.00
Overnight fee -0.026179 %
Charges from full value of position ($-4.97)
Trade size with leverage ~ $20,000.00
Money from leverage ~ $19,000.00

Go to platform
-0.026179%
Short position overnight fee

Short position overnight fee


Margin. Your investment $1,000.00
Overnight fee 0.003957 %
Charges from full value of position ($0.75)
Trade size with leverage ~ $20,000.00
Money from leverage ~ $19,000.00

Go to platform
0.003957%
Overnight fee time 22:00 (UTC)
Min traded quantity 1
Currency USD
Margin 5%
Stock exchange United States of America
Commission on trade 0%

*Information provided by Capital.com

Johnson & Johnson ESG Risk Ratings

High Medium Low Negligible

‘C’ score indicates satisfactory relative ESG performance and moderate degree of transparency in reporting material ESG data publicly.

More ESG coverage

Key Stats
Prev. Close* 158.11
Open* 158.08
1-Year Change* 3.71%
Day's Range* 156.51 - 158.13
52 wk Range 144.95-175.97
Average Volume (10 days) 5.70M
Average Volume (3 months) 137.48M
Market Cap 388.08B
P/E Ratio 32.81
Shares Outstanding 2.41B
Revenue 87.47B
EPS 4.91
Dividend (Yield %) 2.95267
Beta 0.53
Next Earnings Date Jan 23, 2024

All data is provided by Refinitiv, except for data marked with an asterisk, which is *data provided by Capital.com

  • Last Week
  • Last Month
  • Last Year
  • Last two Years
  • Max
  • Daily
  • Weekly
  • Monthly
Date Close Change Change (%) Open High Low
Mar 18, 2024 156.65 -1.43 -0.90% 158.08 158.49 156.45
Mar 15, 2024 158.11 -0.96 -0.60% 159.07 159.35 157.03
Mar 14, 2024 159.01 -1.96 -1.22% 160.97 161.54 158.50
Mar 13, 2024 160.73 -1.69 -1.04% 162.42 162.83 159.71
Mar 12, 2024 162.76 2.01 1.25% 160.75 163.05 160.25
Mar 11, 2024 161.19 2.23 1.40% 158.96 161.35 158.55
Mar 8, 2024 159.49 0.93 0.59% 158.56 160.33 158.08
Mar 7, 2024 158.71 -0.48 -0.30% 159.19 160.29 157.95
Mar 6, 2024 159.31 -0.59 -0.37% 159.90 160.86 158.66
Mar 5, 2024 160.02 0.39 0.24% 159.63 161.18 159.14
Mar 4, 2024 159.76 -2.34 -1.44% 162.10 162.45 158.21
Mar 1, 2024 161.96 0.56 0.35% 161.40 162.49 160.74
Feb 29, 2024 161.35 -0.05 -0.03% 161.40 162.12 160.59
Feb 28, 2024 161.26 0.41 0.25% 160.85 161.55 159.95
Feb 27, 2024 160.96 0.96 0.60% 160.00 160.99 159.60
Feb 26, 2024 160.50 -0.81 -0.50% 161.31 161.92 160.50
Feb 23, 2024 161.60 1.20 0.75% 160.40 162.19 160.11
Feb 22, 2024 160.99 2.67 1.69% 158.32 160.99 157.69
Feb 21, 2024 157.51 0.20 0.13% 157.31 158.64 156.83
Feb 20, 2024 157.55 1.05 0.67% 156.50 158.55 155.95

Johnson & Johnson Events

Time (UTC) Country Event
Tuesday, April 16, 2024

Time (UTC)

12:30

Country

US

Event

Q1 2024 Johnson & Johnson Earnings Release
Q1 2024 Johnson & Johnson Earnings Release

Forecast

-

Previous

-
Friday, April 26, 2024

Time (UTC)

14:00

Country

US

Event

Johnson & Johnson Annual Shareholders Meeting
Johnson & Johnson Annual Shareholders Meeting

Forecast

-

Previous

-
View all events
  • Annual
  • Quarterly
2022 2021 2020 2019 2018
Total revenue 94943 93775 82584 82059 81581
Revenue 94943 93775 82584 82059 81581
Cost of Revenue, Total 30989 29855 28327 27456 26986
Gross Profit 63954 63920 54257 54603 54595
Total Operating Expense 73218 70999 66087 64731 63582
Selling/General/Admin. Expenses, Total 24765 24659 22084 22178 22540
Research & Development 14603 14714 12159 11355 10775
Interest Expense (Income) - Net Operating 814 -370 -410 -183 394
Unusual Expense (Income) 5004 4041 4428 1456 1826
Other Operating Expenses, Total -2957 -1900 -501 2469 1061
Operating Income 21725 22776 16497 17328 17999
Net Income Before Taxes 21725 22776 16497 17328 17999
Net Income After Taxes 17941 20878 14414 15119 15297
Net Income Before Extra. Items 17941 20878 14414 15119 15297
Net Income 17941 20878 14714 15119 15297
Income Available to Common Excl. Extra. Items 17941 20878 14414 15119 15297
Income Available to Common Incl. Extra. Items 17941 20878 14714 15119 15297
Diluted Net Income 17941 20878 14714 15119 15297
Diluted Weighted Average Shares 2663.9 2674 2670.7 2684.3 2728.7
Diluted EPS Excluding Extraordinary Items 6.73486 7.80778 5.39709 5.63238 5.60597
Dividends per Share - Common Stock Primary Issue 4.45 4.19 3.98 3.75 3.54
Diluted Normalized EPS 8.67833 9.22111 6.98515 7.87 6.92185
Total Extraordinary Items 300
Oct 2023 Jul 2023 Apr 2023 Apr 2023 Jan 2023
Total revenue 21351 42413 24746 24746 23706
Revenue 21351 42413 24746 24746 23706
Cost of Revenue, Total 6606 13149 8395 8395 7711
Gross Profit 14745 29264 16351 16351 15995
Total Operating Expense 16134 37394 25483 25483 19505
Selling/General/Admin. Expenses, Total 5400 10302 6138 6138 6512
Research & Development 3447 7158 3563 3563 3841
Interest Expense (Income) - Net Operating -182 -95 -20 80 -77
Unusual Expense (Income) 364 324 179 7579 1871.2
Other Operating Expenses, Total 499 6556 7228 -272 -353.2
Operating Income 5217 5019 -737 -737 4201
Net Income Before Taxes 5217 5019 -737 -737 4201
Net Income After Taxes 4309 4885 -68 -68 3520
Net Income Before Extra. Items 4309 4885 -68 -68 3520
Net Income 26028 5076 -68 -68 3520
Income Available to Common Excl. Extra. Items 4309 4885 -68 -68 3520
Income Available to Common Incl. Extra. Items 26028 5076 -68 -68 3520
Diluted Net Income 26028 5076 -68 -68 3520
Diluted Weighted Average Shares 2549.7 2576.55 2605.5 2605.5 2653.1
Diluted EPS Excluding Extraordinary Items 1.69 1.89595 -0.0261 -0.0261 1.32675
Dividends per Share - Common Stock Primary Issue 1.19 2.32 1.13 1.13 1.13
Diluted Normalized EPS 2.0928 5.98514 3.81117 1.87123 2.02302
Total Extraordinary Items 21719 191
  • Annual
  • Quarterly
2022 2021 2020 2019 2018
Total Current Assets 55294 60979 51237 45274 46033
Cash and Short Term Investments 23519 31608 25185 19287 19687
Cash 4926 2936 2863 2637 2619
Cash & Equivalents 5368 1901 2102 2864 3397
Short Term Investments 13225 26771 20220 13786 13671
Total Receivables, Net 16160 15283 13576 14481 14098
Accounts Receivable - Trade, Net 16160 15283 13576 14481 14098
Total Inventory 12483 10387 9344 9020 8599
Prepaid Expenses 3132 3701 3132 2392 2699
Total Assets 187378 182018 174894 157728 152954
Property/Plant/Equipment, Total - Net 20903 19862 19766 18615 17035
Property/Plant/Equipment, Total - Gross 50353 48579 47804 44289 41851
Accumulated Depreciation, Total -29450 -28717 -28038 -25674 -24816
Goodwill, Net 45231 35246 36393 33639 30453
Intangibles, Net 48325 46392 53402 47643 47611
Other Long Term Assets, Total 17049 17655 12615 11409 11311
Total Current Liabilities 55802 45226 42493 35964 31230
Accounts Payable 11703 11055 9505 8544 7537
Accrued Expenses 29201 29293 28965 23952 20079
Notes Payable/Short Term Debt 11220 1635 832 0 0
Current Port. of LT Debt/Capital Leases 1551 2131 1799 1202 2297
Other Current Liabilities, Total 2127 1112 1392 2266 1317
Total Liabilities 110574 107995 111616 98257 93202
Total Long Term Debt 26888 29985 32635 26494 27684
Long Term Debt 26888 29985 32635 26494 27684
Deferred Income Tax 6374 7487 7214 5958 7506
Other Liabilities, Total 21510 25297 29274 29841 26782
Total Equity 76804 74023 63278 59471 59752
Preferred Stock - Non Redeemable, Net 0 0 0 0 0
Common Stock 3120 3120 3120 3120 3120
Retained Earnings (Accumulated Deficit) 128345 123060 113890 110659 106216
Treasury Stock - Common -41694 -39099 -38490 -38417 -34362
Unrealized Gain (Loss) -27 -3 1 0 0
Other Equity, Total -12940 -13055 -15243 -15891 -15222
Total Liabilities & Shareholders’ Equity 187378 182018 174894 157728 152954
Total Common Shares Outstanding 2613.6 2628.97 2632.51 2632.51 2662.32
Other Current Assets, Total 0 94 950
Long Term Investments 576 1884 1481 1148 511
Oct 2023 Jul 2023 Apr 2023 Apr 2023 Jan 2023
Total Current Assets 53703 60567 64388 55294
Cash and Short Term Investments 23511 28505 24613 23519
Cash 3214 4430 4674 4926
Cash & Equivalents 3503 3570 3364 5368
Short Term Investments 16794 20505 16575 13225
Total Receivables, Net 14798 16777 16350 16160
Accounts Receivable - Trade, Net 14798 16777 16350 16160
Total Inventory 11198 12888 12809 12483
Prepaid Expenses 4196 2397 2921 3132
Total Assets 166061 191686 195969 187378
Property/Plant/Equipment, Total - Net 18821 20576 20174 20903
Property/Plant/Equipment, Total - Gross 45626 51218 50367 49253
Accumulated Depreciation, Total -26805 -30642 -30193 -29450
Goodwill, Net 36124 45440 45575 45231
Intangibles, Net 35021 46246 47448 48325
Long Term Investments 4023 493 505 576
Other Long Term Assets, Total 18369 18364 17879 17049
Total Current Liabilities 44370 54170 60373 55802
Accounts Payable 8355 10443 9909 11703
Accrued Expenses 29246 29339 28219 29201
Notes Payable/Short Term Debt 2000 9800 16900 11220
Current Port. of LT Debt/Capital Leases 1870 1901 1079 1551
Other Current Liabilities, Total 2899 2687 4266 2127
Total Liabilities 94833 116537 125100 110574
Total Long Term Debt 26051 33901 34928 26888
Long Term Debt 26051 33901 34928 26888
Deferred Income Tax 2623 3627 4417 6374
Other Liabilities, Total 21789 23579 25382 21510
Total Equity 71228 75149 70869 76804
Common Stock 3120 3120 3120 3120
Retained Earnings (Accumulated Deficit) 152536 129381 124558 128345
Treasury Stock - Common -75648 -44217 -44183 -41694
Unrealized Gain (Loss) -2 -6 -10 -27
Other Equity, Total -8778 -13129 -12616 -12940
Total Liabilities & Shareholders’ Equity 166061 191686 195969 187378
Total Common Shares Outstanding 2407.18 2598.14 2598.32 2613.6
Preferred Stock - Non Redeemable, Net 0
Other Current Assets, Total 0 7695
Minority Interest 1260
  • Annual
  • Quarterly
2022 2021 2020 2019 2018
Net income/Starting Line 17941 20878 14714 15119 15297
Cash From Operating Activities 21194 23410 23536 23416 22201
Cash From Operating Activities 6970 7390 7231 7009 6929
Deferred Taxes -1663 -2079 -1141 -2476 -1016
Non-Cash Items 1957 1459 42 -101 988
Cash Taxes Paid 5223 4768 4619 4191 4570
Cash Interest Paid 1915 990 904 995 1049
Changes in Working Capital -4011 -4238 2690 3865 3
Cash From Investing Activities -12371 -8683 -20825 -6194 -3167
Capital Expenditures -4009 -3652 -3347 -3498 -3670
Other Investing Cash Flow Items, Total -8362 -5031 -17478 -2696 503
Cash From Financing Activities -8871 -14047 -6120 -18015 -18510
Financing Cash Flow Items 65 395 -627 575 -148
Total Cash Dividends Paid -11682 -11032 -10481 -9917 -9494
Issuance (Retirement) of Stock, Net -4706 -2420 -2107 -5792 -4919
Issuance (Retirement) of Debt, Net 7452 -990 7095 -2881 -3949
Foreign Exchange Effects -312 -178 89 -9 -241
Net Change in Cash -360 502 -3320 -802 283
Apr 2023 Apr 2023 Jan 2023 Oct 2022 Jul 2022
Net income/Starting Line -68 17941 14421 9963
Cash From Operating Activities 3257 21194 15844 9560
Cash From Operating Activities 1880 6970 5198 3513
Deferred Taxes -1543 -1663 -2488 -2349
Non-Cash Items 725 1957 1485 1175
Changes in Working Capital 2263 -4011 -2772 -2742
Cash From Investing Activities 3315 -12371 -7974 -6273
Capital Expenditures -863 -4009 -2422 -1470
Other Investing Cash Flow Items, Total 4178 -8362 -5552 -4803
Cash From Financing Activities 6138 -8871 -10571 -6646
Financing Cash Flow Items -252 65 1806 802
Total Cash Dividends Paid -2942 -11682 -8728 -5758
Issuance (Retirement) of Stock, Net -3548 -4706 -3808 -1730
Issuance (Retirement) of Debt, Net 12880 7452 159 40
Foreign Exchange Effects 28 -312 -431 -145
Net Change in Cash 12738 -360 -3132 -3504
Investor Name Investor Type Percent Outstanding Shares Held Shares change Holdings Date Turnover Rating
The Vanguard Group, Inc. Investment Advisor/Hedge Fund 10.2364 246418524 569768 2023-06-30 LOW
State Street Global Advisors (US) Investment Advisor/Hedge Fund 5.8919 141833756 1568633 2023-06-30 LOW
BlackRock Institutional Trust Company, N.A. Investment Advisor 5.3464 128702928 -1152148 2023-06-30 LOW
Geode Capital Management, L.L.C. Investment Advisor/Hedge Fund 2.0645 49697798 990298 2023-06-30 LOW
State Farm Insurance Companies Insurance Company 1.3158 31675492 0 2023-06-30 LOW
Capital International Investors Investment Advisor 1.1559 27825795 10724110 2023-06-30 LOW
Norges Bank Investment Management (NBIM) Sovereign Wealth Fund 1.0839 26093398 2295051 2022-12-31 LOW
T. Rowe Price Associates, Inc. Investment Advisor 1.0094 24299765 1144263 2023-06-30 LOW
Wellington Management Company, LLP Investment Advisor/Hedge Fund 0.9536 22955840 -2430935 2023-06-30 LOW
Morgan Stanley Smith Barney LLC Investment Advisor 0.9286 22355142 92730 2023-06-30 LOW
MFS Investment Management Investment Advisor/Hedge Fund 0.8351 20102965 -288668 2023-06-30 LOW
Northern Trust Investments, Inc. Investment Advisor/Hedge Fund 0.8273 19914659 -1746201 2023-06-30 LOW
Legal & General Investment Management Ltd. Investment Advisor/Hedge Fund 0.8218 19782007 1046097 2023-06-30 LOW
Fidelity Management & Research Company LLC Investment Advisor 0.7857 18913505 2153767 2023-06-30 LOW
JP Morgan Asset Management Investment Advisor 0.7352 17697419 2080595 2023-06-30 LOW
Wells Fargo Advisors Research Firm 0.7142 17193465 15312 2023-06-30 LOW
Charles Schwab Investment Management, Inc. Investment Advisor 0.7113 17123285 -23034 2023-06-30 LOW
BofA Global Research (US) Research Firm 0.7069 17017658 -3806531 2023-06-30 LOW
BlackRock Asset Management Ireland Limited Investment Advisor 0.6824 16427920 117449 2023-06-30 LOW
BlackRock Investment Management (UK) Ltd. Investment Advisor/Hedge Fund 0.6704 16139108 -242372 2023-06-30 LOW

Trading calculator

Calculate your hypothetical P&L if you had opened a CFD trade on a certain date (select a date) and closed on a different date (select a date).

Trade commission
0
  • 1:1
Leverage
1:1
  • 20
  • 100
  • 500
  • 1000
  • 10000
Investment
Trade size (Leverage x Investement):
Open

Close

Short Long

For the avoidance of doubt, this calculation does not include the costs of holding a position overnight (for which there will be additional charges)

Johnson & Johnson Company profile

What is Johnson & Johnson?

Johnson & Johnson is a holding company with its subsidiaries involved in the production and distribution of consumer healthcare products, medical devices and pharmaceutical products. Its consumer segment is represented by the brands Johnson's, Clean & Clear, Le Petite Marseillais and others. The pharmaceutical division ships products for almost all therapeutic fields and treatments for autoimmune disorders. The medical division manufactures devices for orthopaedic, diabetes care and other fields.

Financial stability has been one of Johnson & Johnson’s hallmarks for decades. The company has raised its dividend for 55 successive years, and remains one of just two U.S. companies to have a triple-A credit rating.Fortune included Johnson & Johnson in its list of the largest American corporations.

Johnson & Johnson also prides itself on its corporate social responsibility, and sets out its values in a Credo. In it, the company declares: “We believe our first responsibility is to the doctors, nurses and patients, to mothers and fathers and all others who use our products and services […] We must constantly strive to reduce our costs in order to maintain reasonable prices […] Our suppliers and distributors must have an opportunity to make a fair profit.”

Who are the key people at Johnson & Johnson?

Alex Gorsky is Chairman of the Board of Directors and Chief Executive Officer. Other key figures include Chief Financial Officer Dominic Caruso; Joaquin Duato, Worldwide Chairman, Pharmaceuticals; Jorge Mesquita, Worldwide Chairman, Consumer; and Ashley McEvoy, Company Group Chairman, Consumer Medical Devices.

What is the modern history of Johnson & Johnson?

Johnson & Johnson was founded by three brothers in 1885, incorporated in 1887, and chaired by successive members of the Johnson family until 1963. The company was listed in 1944 and steadily expanded from its home market to Latin America, Europe, Africa and Asia. In 1959, Johnson & Johnson acquired pharmaceutical manufacturer Cilag AG – a big landmark for its pharmaceutical division. The medical and consumer health divisions saw major growth in the latter decades of the 20thcentury.

What are the latest developments at Johnson & Johnson?

In its full year 2017 results, Johnson & Johnson reported worldwide sales of $76.5 billion, an increase of 6.3% on the previous year.Excluding the impact of acquisitions and divestitures, worldwide sales for 2017 were 2.4% higher than in 2016.Net earnings for the full year 2017 were $1.3 billion, and adjusted full year earnings per share were $7.30, an increase of 8.5% on 2016.

The Johnson & Johnson share price, which hovered between $50 and $60 for most of the first decade of this century, started taking off in 2012. By May 2014 the shares were trading at over $100, and in January 2018 they went as high as $147. As of 3 April 2018, they stood at just over $127. To find out how the shares are doing right now, follow Capital.com. Our JNJ chart puts all the information at your fingertips.

Where does Johnson & Johnson operate?

Johnson & Johnson is headquartered in New Brunswick in the U.S. state of New Jersey. The company’s 250 or so subsidiaries operate in 60 countries around the world, and its products are sold in more than 175 countries. So it’s a truly global company, with high levels of brand recognition.

Where is Johnson & Johnson traded?

Johnson & Johnson is listed on the New York Stock Exchange (NYSE), and the shares are a component of the Dow Jones Industrial Average. Check out Capital.com for the latest JNJ chart. We’ll keep you up to date and in the picture.

Industry: Pharmaceuticals (NEC)

One Johnson & Johnson Plaza
NEW BRUNSWICK
NEW JERSEY 08933
US

Income Statement

  • Annual
  • Quarterly

News

Bank of Japan Preview: will the BOJ end negative interest rates?

The Bank of Japan meets on Tuesday 19th of March. We preview what to expect from the BOJ decision and how it might impact the USD/JPY and Nikkei 225.

08:44, 18 March 2024

Higher CPI leaves traders unfazed as US equities continue to build momentum

The latest US CPI reading hasn’t gone how the Federal would have hoped. Consumer prices came in higher than expected in February for the third month in a row.

12:42, 15 March 2024

Four reasons why Bitcoin is surging to record highs

Bitcoin has surged to record highs. We discuss the four factors pushing Bitcoin higher and analyse the technicals of the cryptocurrency’s technicals.

10:18, 14 March 2024

China’s National People’s Congress: The markets have again been left wanting more

China’s National People’s Congress (NPC) is underway, and the markets have so far been disappointed by what’s been delivered by the country’s central government. We look at some of the significant takeaways from the event, discuss China’s current economic conditions, and analyse the China A50.

08:23, 8 March 2024
Facade on the Federal Reserve Building in Washington DC

Central Banks: which one will cut first?

Central banks dominate the calendar in March and markets try to anticipate which one will be the first one to cut

13:14, 6 March 2024

Nvidia (NVDA) confronts high expectations for Q4 results

Nvidia is arguably the hottest company on the planet. The company reports its Q4 results after the closing bell on Wednesday, the 21st of February. We preview what to expect from Nvidia’s earnings and analyse the technicals of its stock price.

12:13, 20 February 2024

UK Bank Earnings: What to expect from Lloyds, Barclays and HSBC?

UK banks will be in the spotlight in the week ahead as the European earnings season continues

16:38, 16 February 2024

People also watch

US100

17,937.20 Price
+0.680% 1D Chg, %
Long position overnight fee -0.0262%
Short position overnight fee 0.0040%
Overnight fee time 22:00 (UTC)
Spread 1.8

Oil - Crude

82.05 Price
+1.730% 1D Chg, %
Long position overnight fee 0.0269%
Short position overnight fee -0.0488%
Overnight fee time 22:00 (UTC)
Spread 0.030

BTC/USD

65,923.55 Price
-3.420% 1D Chg, %
Long position overnight fee -0.0616%
Short position overnight fee 0.0137%
Overnight fee time 22:00 (UTC)
Spread 106.00

Gold

2,161.74 Price
+0.270% 1D Chg, %
Long position overnight fee -0.0188%
Short position overnight fee 0.0106%
Overnight fee time 22:00 (UTC)
Spread 0.30

Still looking for a broker you can trust?

Join the 580.000+ traders worldwide that chose to trade with Capital.com

1. Create & verify your account 2. Make your first deposit 3. You’re all set. Start trading